pharmaceutical company

Lilly’s GLP-1 Pill: A Weight-Loss Revolution?

by

Archyde Eli Lilly’s Oral Obesity Drug Shows Promise, Stock Surges april 18, 2025 Eli Lilly’s stock experienced a significant surge following the release of positive Phase 3 trial results for its experimental oral obesity drug, Orfoglipron. The data suggests a potential shift in how obesity and diabetes are treated, offering a convenient alternative to injectable … Read more

Ozempic Face Phenomenon Sparks Boom in Cosmetic Filler Sales

by

The ‍rise of Ozempic face, a phenomenon linked to the use of weight-loss⁢ drugs, has sparked a meaningful surge in the demand for face⁣ fillers. Flemming Ornskov, the chief⁣ executive of the Swiss dermatology company⁢ Galderma, highlighted that these drugs often lead to “facial ⁢sagging,” prompting many individuals to seek cosmetic solutions to restore their … Read more